Latest Period
Q2 2026
Security Snapshot
TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) Institutional Ownership
CUSIP: 898920103
13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026
Institutions Reporting
89
Shares (Excl. Options)
8,978,603
Price
$2.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- HURA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 8,978,603
- Total 13F value
- $21,010,048
- Portfolio coverage rank
- 0%
- Share change
- -471,770
- Value change
- -$793,557
- Number of holders
- 89
- Shares outstanding
- 67,076,500
- SEC-reported price per share
- $2.30
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HURA - TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share is tracked under CUSIP 898920103.
- 89 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 89 to 89 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $17,010,597 to $21,010,048.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 89 institutions filings for Q2 2026.
Security key
898920103
Latest holder period
Q2 2026
13F holders
89
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
HURA full holder history
TuHURA Biosciences, Inc./NV SEC filings
TuHURA Biosciences, Inc./NV company facts
TuHURA Biosciences, Inc./NV insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 898920103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
HURA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 9.1% | $4,424,244 | 6,060,608 | Highbridge Capital Management, LLC | 31 Dec 2025 | |||
| Bianco James A. | 4.6% | $6,695,576 | 3,085,519 | James A. Bianco, M.D. | 18 Aug 2026 | |||
| VANGUARD GROUP INC | 4.4% | -13% | $5,628,772 | +$87,856 | 2,269,666 | +1.6% | The Vanguard Group | 30 Sep 2025 |
| CA Patel F&F Investments, LLC | 0.9% | $1,028,634 | 447,232 | CA Patel F&F Investments, LLC | 12 Jun 2025 | |||
| KP Biotech Group LLC | 0.9% | $1,028,634 | 447,232 | KP Biotech Group LLC | 12 Jun 2025 |
As of 30 Jun 2026, 89 institutional investors reported holding 8,978,603 shares of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA). This represents 13% of the company’s total 67,076,500 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 2,267,901 | +9.3% | 0% | $5,306,888 |
| NORTHERN TRUST CORP | 2.4% | 1,621,042 | +444% | 0% | $3,793,238 |
| BlackRock, Inc. | 1% | 690,088 | -72% | 0% | $1,614,806 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.72% | 484,219 | -51% | 0% | $1,133,719 |
| MILLENNIUM MANAGEMENT LLC | 0.68% | 454,535 | 0% | $1,063,612 | |
| AQR CAPITAL MANAGEMENT LLC | 0.63% | 424,600 | -30% | 0% | $993,563 |
| VANGUARD FIDUCIARY TRUST CO | 0.37% | 251,186 | -13% | 0% | $587,775 |
| CITADEL ADVISORS LLC | 0.35% | 232,319 | 0% | $543,627 | |
| STATE STREET CORP | 0.28% | 188,404 | -63% | 0% | $440,865 |
| JANE STREET GROUP, LLC | 0.24% | 163,891 | 0% | $383,505 | |
| Apollon Wealth Management, LLC | 0.23% | 156,519 | -0.94% | 0% | $366,254 |
| Qube Research & Technologies Ltd | 0.22% | 145,595 | 0% | $340,692 | |
| MORGAN STANLEY | 0.21% | 143,257 | +501% | 0% | $335,222 |
| GOLDMAN SACHS GROUP INC | 0.2% | 131,768 | +88% | 0% | $308,337 |
| Bank of New York Mellon Corp | 0.18% | 121,662 | -42% | 0% | $284,689 |
| XTX Topco Ltd | 0.15% | 100,424 | +772% | 0% | $234,992 |
| WealthShield Partners, LLC | 0.14% | 91,530 | 0% | 0.03% | $214,180 |
| Aster Capital Management (DIFC) Ltd | 0.13% | 89,690 | 0.04% | $209,875 | |
| CAPTRUST FINANCIAL ADVISORS | 0.13% | 88,373 | 0% | $206,793 | |
| Cetera Investment Advisers | 0.09% | 61,620 | -56% | 0% | $144,191 |
| UBS Group AG | 0.08% | 56,321 | -9.3% | 0% | $131,791 |
| Catalyst Funds Management Pty Ltd | 0.07% | 47,201 | 0.01% | $110,450 | |
| BRIGHTON JONES LLC | 0.07% | 47,010 | -3.2% | 0% | $110,004 |
| TUDOR INVESTMENT CORP ET AL | 0.07% | 45,115 | 0% | $105,569 | |
| BANK OF AMERICA CORP /DE/ | 0.06% | 42,506 | -46% | 0% | $99,464 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 8,978,603 | $21,010,048 | -$793,557 | $2.34 | 89 |
| 2026 Q1 | 9,507,865 | $17,010,597 | +$4,956,161 | $1.79 | 89 |
| 2025 Q4 | 6,452,534 | $4,884,399 | +$73,074 | $0.76 | 64 |
| 2025 Q3 | 6,118,579 | $15,175,582 | -$534,149 | $2.48 | 67 |
| 2025 Q2 | 6,389,148 | $14,249,317 | +$6,116,594 | $2.23 | 48 |
| 2025 Q1 | 3,655,045 | $11,806,197 | +$4,737,391 | $3.23 | 26 |
| 2024 Q4 | 2,159,487 | $8,838,702 | +$8,791,398 | $4.09 | 26 |